Is iron sucrose (iron sucrose) 100mg every hemodialysis session for 10 doses, then every 2 weeks, an appropriate treatment for a patient with low Transferrin Saturation (TSAT) of 10% and when should Complete Blood Counts (CBC) and iron studies be repeated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Sucrose Dosing for TSAT 10% in Hemodialysis

Your proposed regimen of iron sucrose 100mg every hemodialysis session for 10 doses, then every 2 weeks, is appropriate for initial repletion but requires modification for maintenance dosing based on iron parameters. 1, 2, 3

Initial Loading Phase (First 10 Doses)

  • Administer iron sucrose 100mg undiluted as slow IV push over 2-5 minutes during each hemodialysis session for 10 consecutive sessions, delivering a total of 1000mg over 8-10 weeks 1, 3, 4
  • This loading regimen is specifically designed for hemodialysis patients with severe iron deficiency (TSAT 10% is well below the target of ≥20%) 1, 2
  • The 100mg dose per session is safe and does not require a test dose 3, 4, 5

Critical Monitoring Timeline

Do NOT check iron studies immediately after completing the loading phase. The most common pitfall is checking labs too early, which yields falsely elevated results. 2

  • Wait 7 days after the 10th (final) dose before checking TSAT, ferritin, and CBC 2
  • During the loading phase itself, if the patient is receiving regular IV iron, check TSAT and ferritin at least every 3 months (not more frequently unless clinically indicated) 1
  • Check CBC monthly during the loading phase to assess hemoglobin response 1

Maintenance Phase Decision Algorithm

After completing 10 doses and waiting 7 days, your maintenance strategy depends entirely on the iron parameters: 1, 2

If TSAT ≥20% and ferritin ≥100 ng/mL (Target Achieved):

  • Switch to maintenance dosing: 25-100mg iron sucrose every 1-2 weeks (not the full 100mg every 2 weeks you proposed) 2
  • The goal is to provide 250-1000mg total iron within any 12-week period 2
  • Your proposed "100mg every 2 weeks" would deliver 600mg per 12 weeks, which falls within this range and is acceptable 2

If TSAT <20% or ferritin <100 ng/mL (Target Not Achieved):

  • Administer a second 10-dose course of 100mg per session 1, 2
  • Reassess 7 days after completing the second course 2

If TSAT >50% or ferritin >800 ng/mL (Overload Risk):

  • Immediately stop all iron supplementation 2, 6
  • Recheck parameters in 2-4 weeks 6
  • Resume at one-third to one-half the previous dose only when TSAT falls below 50% 2, 6

Ongoing Monitoring Schedule

Once target hemoglobin is achieved and patient is on maintenance iron: 1

  • Check TSAT, ferritin, and CBC every 3 months 1, 2
  • If iron parameters remain stable (TSAT 20-50%, ferritin 100-800 ng/mL), continue quarterly monitoring 1, 2
  • Weekly doses of 100-125mg or less do not need to be interrupted to obtain accurate iron measurements 1

Expected Clinical Response

  • Hemoglobin should begin rising after 3 doses (approximately 3 weeks) and continue improving through 5 weeks after the 10th dose 4
  • If no hemoglobin increase occurs despite achieving TSAT ≥20% and ferritin ≥100 ng/mL after the first course, proceed with the second 10-dose course before concluding the patient is iron-refractory 1, 2
  • The National Kidney Foundation guidelines indicate patients are unlikely to respond further once TSAT exceeds 50% or ferritin exceeds 800 ng/mL 1, 2

Key Safety Considerations

  • Iron sucrose 100mg per dose has an excellent safety profile with no serious adverse events reported, even in patients with prior iron dextran sensitivity 4, 5
  • No test dose is required for iron sucrose 3, 4
  • The regimen can be administered safely during the first hour of dialysis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Sucrose Treatment for Severe Iron Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Guideline

Iron Overload Prevention and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.